Go here to read the rest:
MedMira Announces Product Update

Read the original here:
Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Acute Myeloid Leukemia (AML)

Visit link:
Polydex Pharmaceuticals Issues Third Quarter Financial Results

Here is the original post:
Auxly Announces Closing of $13.8 Million Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option

See the original post here:
Havn Life Sciences announces increase in Bought Deal Financing to $10 Million

Read the original here:
GT Gain Therapeutics SA Announces Funding from the Swiss Innovation Agency Supporting a 3-year Research Collaboration Project with the Institute for...

Excerpt from:
UPDATE - Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Acute Myeloid Leukemia (AML)

View post:
Arecor Limited: First Patient Dosed in Phase I Clinical Trial of Ultra-Concentrated Rapid Acting Insulin Candidate, AT278, for Diabetes

See the original post:
Arch Biopartners Receives Government of Canada Funding to Support Phase II Therapeutic Trial of Metablok for COVID-19

Read the original here:
Mereo BioPharma Provides Update on AIM Delisting and Continued Listing of its ADSs on Nasdaq, and Provides Update on agreements with Silicon Valley...

See the original post here:
LIDDS AB (publ) announces the appointment of Nina Herne as CEO

Read the original here:
Transactions in connection with share buyback program

Read more:
Sio Gene Therapies Announces Positive Six-Month Follow-Up Data from Low-Dose Cohort of Phase 1/2 Trial of AXO-AAV-GM1 for GM1 Gangliosidosis

Read the original here:
ImmuCell Announces Restructuring of its Bank Debt

Read more from the original source:
Gilead  and  Galapagos  announce  New  Commercialization  and  Development  Agreement  for  Jyseleca®  (filgotinib)  

Go here to read the rest:
Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab

Continued here:
Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2020

Originally posted here:
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Original post:
vTv Therapeutics Announces Topline Results of Phase 2 Elevage Study of Azeliragon in Patients with Mild Alzheimer’s Disease and Type 2 Diabetes

Originally posted here:
Novartis announces positive FDA Advisory Committee recommendation for use of Entresto® to treat patients with HFpEF